These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25106114)

  • 1. Role of astrocytic glycolytic metabolism in Alzheimer's disease pathogenesis.
    Fu W; Jhamandas JH
    Biogerontology; 2014 Dec; 15(6):579-86. PubMed ID: 25106114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive astrocytes give neurons less support: implications for Alzheimer's disease.
    Steele ML; Robinson SR
    Neurobiol Aging; 2012 Feb; 33(2):423.e1-13. PubMed ID: 21051108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease.
    Zheng J; Xie Y; Ren L; Qi L; Wu L; Pan X; Zhou J; Chen Z; Liu L
    Mol Metab; 2021 May; 47():101180. PubMed ID: 33556642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of astrocytes to metabolic dysfunction in the Alzheimer's disease brain.
    Zulfiqar S; Garg P; Nieweg K
    Biol Chem; 2019 Aug; 400(9):1113-1127. PubMed ID: 31188740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inverse-Warburg effect and the origin of Alzheimer's disease.
    Demetrius LA; Simon DK
    Biogerontology; 2012 Dec; 13(6):583-94. PubMed ID: 23086530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity.
    Vincent AJ; Gasperini R; Foa L; Small DH
    J Alzheimers Dis; 2010; 22(3):699-714. PubMed ID: 20847426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
    Avila-Muñoz E; Arias C
    Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
    Assefa BT; Gebre AK; Altaye BM
    Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
    Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
    Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
    Kubo T; Nishimura S; Kumagae Y; Kaneko I
    J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
    Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
    Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of astrocytes to Alzheimer's disease.
    Birch AM
    Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated astrocytes: a therapeutic target in Alzheimer's disease?
    Fuller S; Münch G; Steele M
    Expert Rev Neurother; 2009 Nov; 9(11):1585-94. PubMed ID: 19903019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.
    Sharma A; Kazim SF; Larson CS; Ramakrishnan A; Gray JD; McEwen BS; Rosenberg PA; Shen L; Pereira AC
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21800-21811. PubMed ID: 31591195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.
    Harris RA; Tindale L; Cumming RC
    Biogerontology; 2014 Dec; 15(6):559-77. PubMed ID: 25305052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.
    Vardjan N; Verkhratsky A; Zorec R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.